AR128418A1 - Inhibidores de la proteína tirosina fosfatasa y usos de estos - Google Patents

Inhibidores de la proteína tirosina fosfatasa y usos de estos

Info

Publication number
AR128418A1
AR128418A1 ARP230100235A ARP230100235A AR128418A1 AR 128418 A1 AR128418 A1 AR 128418A1 AR P230100235 A ARP230100235 A AR P230100235A AR P230100235 A ARP230100235 A AR P230100235A AR 128418 A1 AR128418 A1 AR 128418A1
Authority
AR
Argentina
Prior art keywords
alkyl
heterocycloalkyl
heteroaryl
aryl
cycloalkyl
Prior art date
Application number
ARP230100235A
Other languages
English (en)
Spanish (es)
Inventor
Jason Roland
Sergio G Duron
Original Assignee
Nerio Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nerio Therapeutics Inc filed Critical Nerio Therapeutics Inc
Publication of AR128418A1 publication Critical patent/AR128418A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01—Five-membered rings
    • C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04—Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/10—1,2,5-Thiadiazoles; Hydrogenated 1,2,5-thiadiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/433—Thidiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
ARP230100235A 2022-02-02 2023-02-01 Inhibidores de la proteína tirosina fosfatasa y usos de estos AR128418A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US202263305786P 2022-02-02 2022-02-02

Publications (1)

Publication Number Publication Date
AR128418A1 true AR128418A1 (es) 2024-05-08

Family

ID=87552989

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP230100235A AR128418A1 (es) 2022-02-02 2023-02-01 Inhibidores de la proteína tirosina fosfatasa y usos de estos

Country Status (7)

Country Link
US (1) US20250136564A1 (cg-RX-API-DMAC7.html)
EP (1) EP4472976A4 (cg-RX-API-DMAC7.html)
JP (1) JP2025507292A (cg-RX-API-DMAC7.html)
CN (1) CN119137117A (cg-RX-API-DMAC7.html)
AR (1) AR128418A1 (cg-RX-API-DMAC7.html)
TW (1) TW202337459A (cg-RX-API-DMAC7.html)
WO (1) WO2023150535A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL314650A (en) * 2022-02-02 2024-09-01 Nerio Therapeutics Inc Protein tyrosine phosphatase inhibitors and uses thereof
WO2024243441A1 (en) 2023-05-24 2024-11-28 Kumquat Biosciences Inc. Heterocyclic compounds and uses thereof
WO2025030008A1 (en) * 2023-08-02 2025-02-06 Nerio Therapeutics, Inc. Protein tyrosine phosphatase inhibitor combinations
CN120004876B (zh) * 2023-11-16 2026-02-06 英矽智能科技(上海)有限公司 蛋白酪氨酸磷酸酶抑制剂及其应用
CN117343052B (zh) * 2023-12-04 2024-02-06 英矽智能科技(上海)有限公司 蛋白酪氨酸磷酸酶抑制剂及其应用
WO2026108900A1 (zh) * 2024-11-20 2026-05-28 湖北生物医药产业技术研究院有限公司 作为蛋白质酪氨酸磷酸酶抑制剂的含苯并环类化合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA94724C2 (en) * 2005-12-08 2011-06-10 Новартис Аг Thiadiazolidinone derivatives as antidiabetic agents
UA94921C2 (en) * 2005-12-08 2011-06-25 Новартис Аг 1-orthofluorophenyl substituted 1, 2, 5-thiazolidinedione derivatives as ptp-as inhibitors
JP2016516004A (ja) * 2013-02-22 2016-06-02 メルク・シャープ・アンド・ドーム・コーポレーションMerck Sharp & Dohme Corp. 抗糖尿病二環式化合物
KR102983496B1 (ko) * 2019-03-14 2026-06-29 칼리코 라이프 사이언시스 엘엘씨 단백질 티로신 포스파타제 억제제 및 이의 사용 방법
EP4211122A1 (en) * 2020-09-11 2023-07-19 Calico Life Sciences LLC Protein tyrosine phosphatase inhibitors and methods of use thereof
EP4305030A4 (en) * 2021-03-11 2025-05-21 Kumquat Biosciences Inc. HETEROCYCLES AND THEIR USES

Also Published As

Publication number Publication date
TW202337459A (zh) 2023-10-01
EP4472976A1 (en) 2024-12-11
EP4472976A4 (en) 2026-03-25
JP2025507292A (ja) 2025-03-18
WO2023150535A1 (en) 2023-08-10
US20250136564A1 (en) 2025-05-01
CN119137117A (zh) 2024-12-13

Similar Documents

Publication Publication Date Title
AR128417A1 (es) Inhibidores de la proteína tirosina fosfatasa y usos de estos
AR125425A1 (es) Inhibidores de proteina tirosina fosfatasa y sus metodos de uso
AR118374A1 (es) Inhibidores de la proteína tirosina fosfatasa y métodos para usarlos
PE20251071A1 (es) Inhibidores de kras
AR129339A1 (es) Inhibidores de parg
AR127500A1 (es) Inhibidores de la proteína que contiene el dominio de prolil hidroxilasa (phd) y usos de los mismos
UY37133A (es) Derivados de pirazolo[1,5-a]pirazin-4-ilo
AR117900A1 (es) Pirazolopiridinas y triazolopiridinas como inhibidores de a2a / a2b
AR089489A1 (es) Derivados de tieno[3,2-d]pirimidina que tienen actividad inhibidora por las quinasas de las proteinas
UY31027A1 (es) Derivados de tetrahidroindol y tetrahidroindazol
AR096846A1 (es) Dihidroquinoxalinonas y dihidropiridopirazinonas modificadas como inhibidores de la proteína bet
AR102799A1 (es) Profármacos de agonistas fenólicos de trpv1
MD20210033A2 (ro) Compuşi, compoziţii şi metode pentru modularea activităţii CDK9
AR112900A1 (es) Compuesto derivado de pirazol y uso de este
BR112022013488A2 (pt) Pirazolo-pirimidinas substituídas e seu uso
AR114082A1 (es) INHIBIDORES DE LA PI4KIIIb
CL2021003139A1 (es) Compuestos tricíclicos
BR0212435A (pt) Derivados de 3-(4,5,6,7-tetraidroindol-2-ilmetilideno)-2-indolinona como inibidores de cinase
PE20081113A1 (es) Inhibidores virales policiclicos
AR128669A1 (es) INHIBIDORES DE DIACILGLICEROL CINASA (DGK) a Y USOS DE LOS MISMOS
AR127355A1 (es) Moduladores de micromoléculas de la actividad de la glucocerebrosidasa y usos de estos
AR127277A1 (es) Composiciones y métodos para modular la formación de inclusión y gránulos de estrés
AR050963A1 (es) Derivados bis-azaindolicos, su utilizacion farmaceutica como inhibidores de cinasas y su uso en la fabricacion de medicamentos para el tratamiento de los canceres.
AR095895A1 (es) Compuestos de acil-imino-piridina n-sustituidos y derivados para combatir plagas de animales
AR107974A1 (es) Análogos de nucleósidos alquinil como inhibidores de rinovirus humanos

Legal Events

Date Code Title Description
FB Suspension of granting procedure